The increased understanding of the hallmarks of cancer along with the results from different in vitro studies have provided information on the role of the signaling pathways commanded by the axis SP/NK-1R in human cancer and treatment resistance, as well as the potential utility of NK-1R antagonists as antitumor agents that could also be of help to overcome resistance. This evidence concerns the gene TACR1 and cancer.